Left ventricular hypertrophy and diastolic dysfunction in children with sickle cell disease are related to asleep and

Mark C Johnson1, Fenella J Kirkham, Susan Redline

  • 1Department of Pediatrics, Washington University School of Medicine, 660 S. Euclid Avenue, St Louis, MO 63110, USA.

Blood
|April 10, 2010
PubMed

Insights

Low oxygen saturation during sleep and waking is linked to left ventricular abnormalities in children with sickle cell disease (SCD). This finding highlights the impact of breathing issues on cardiac health in pediatric SCD patients.

Area of Science:

  • Cardiology
  • Pediatrics
  • Sleep Medicine
  • Hematology

Background:

  • Sickle cell disease (SCD) is associated with premature death and cardiac abnormalities.
  • The underlying mechanisms connecting SCD to cardiac issues, particularly in children, remain unclear.
  • Sleep-disordered breathing is a potential, yet understudied, contributor to cardiac dysfunction in pediatric SCD.

Purpose of the Study:

  • To investigate the association between sleep-disordered breathing and cardiac abnormalities in children with SCD.
  • To test the hypothesis that reduced oxygen saturation during sleep and waking contributes to cardiac dysfunction in this population.

Main Methods:

  • An observational study involving 44 children with SCD (mean age 10.1 years).
  • Evaluations included standard and tissue Doppler echocardiography, overnight polysomnography, and measurement of average asleep and waking oxygen saturation.
  • Data were collected within a 7-day period for each participant.

Main Results:

  • Eccentric left ventricular (LV) hypertrophy was identified in 46% of the children.
  • Lower average asleep and waking oxygen saturation were significantly associated with increased LV mass index.
  • LV diastolic dysfunction was also correlated with reduced oxygen saturation levels.

Conclusions:

  • Low oxygen saturation during both sleep and waking is associated with left ventricular abnormalities in children with SCD.
  • These findings suggest that sleep-disordered breathing may play a role in the cardiac complications observed in pediatric SCD.
  • Further research is warranted to explore therapeutic interventions targeting sleep-disordered breathing in this vulnerable population.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.